Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Tax Provisions: 2020-2022

Historic Tax Provisions for Insight Molecular Diagnostics (IMDX) over the last 3 years, with Dec 2022 value amounting to -$8.1 million.

  • Insight Molecular Diagnostics' Tax Provisions fell 161.01% to -$97,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$5.7 million, marking a year-over-year change of. This contributed to the annual value of -$8.1 million for FY2022, which is 12.90% up from last year.
  • Insight Molecular Diagnostics' Tax Provisions amounted to -$8.1 million in FY2022, which was up 12.90% from -$9.3 million recorded in FY2021.
  • Insight Molecular Diagnostics' 5-year Tax Provisions high stood at -$1.3 million for FY2020, and its period low was -$9.3 million during FY2021.
  • Its 3-year average for Tax Provisions is -$6.2 million, with a median of -$8.1 million in 2022.
  • In the last 5 years, Insight Molecular Diagnostics' Tax Provisions slumped by 615.38% in 2021 and then increased by 12.90% in 2022.
  • Insight Molecular Diagnostics' Tax Provisions (Yearly) stood at -$1.3 million in 2020, then crashed by 615.38% to -$9.3 million in 2021, then increased by 12.90% to -$8.1 million in 2022.